RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 96 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $5,199,000 | +4.2% | 2,331,366 | -2.8% | 0.20% | -3.8% |
| Q1 2016 | $4,988,000 | -31.4% | 2,397,855 | 0.0% | 0.21% | -27.9% |
| Q4 2015 | $7,266,000 | +22.7% | 2,397,855 | 0.0% | 0.29% | +28.4% |
| Q3 2015 | $5,923,000 | -23.0% | 2,397,855 | 0.0% | 0.23% | -10.5% |
| Q2 2015 | $7,697,000 | -10.1% | 2,397,855 | 0.0% | 0.26% | -7.6% |
| Q1 2015 | $8,560,000 | +57.3% | 2,397,855 | 0.0% | 0.28% | +41.3% |
| Q4 2014 | $5,443,000 | +17.0% | 2,397,855 | 0.0% | 0.20% | +15.3% |
| Q3 2014 | $4,652,000 | -46.6% | 2,397,855 | 0.0% | 0.17% | -51.4% |
| Q2 2014 | $8,704,000 | +118.4% | 2,397,855 | +133.4% | 0.35% | +114.7% |
| Q1 2014 | $3,986,000 | +83.2% | 1,027,443 | +34.5% | 0.16% | +44.2% |
| Q4 2013 | $2,176,000 | -43.1% | 763,675 | -28.5% | 0.11% | -36.5% |
| Q3 2013 | $3,822,000 | -57.8% | 1,067,726 | -60.6% | 0.18% | -58.3% |
| Q2 2013 | $9,052,000 | – | 2,710,053 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |